A Randomised Phase 2 Study of Intermittent Versus Continuous Dosing of Dabrafenib Plus Trametinib in Patients with BRAFV600 Mutant Advanced Melanoma (INTERIM).
EUROPEAN JOURNAL OF CANCER（2024）
关键词
Dabrafenib,Trametinib,BRAF,Metastatic melanoma,Intermittent dosing,Continuous dosing,Scheduling,Circulating tumour DNA
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要